Metabolomics to unveil and understand phenotypic diversity between pathogen populations
about
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistanceComparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmaniaFunctional genomics of trypanosomatidsCurrent challenges in treatment options for visceral leishmaniasis in India: a public health perspectiveExperimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocolBenznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomicsA Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantumMetabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid MetabolismIn vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.mzMatch-ISO: an R tool for the annotation and relative quantification of isotope-labelled mass spectrometry dataLC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case.Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates.Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI/MS, and multivariate data analysis.Metabolic variation during development in culture of Leishmania donovani promastigotes.ATG5 is essential for ATG8-dependent autophagy and mitochondrial homeostasis in Leishmania majorLarge-scale metabolome analysis and quantitative integration with genomics and proteomics data in Mycoplasma pneumoniae.Two birds with one stone: doing metabolomics with your proteomics kit.The newest "omics"--metagenomics and metabolomics--enter the battle against the neglected tropical diseasesCombining DI-ESI-MS and NMR datasets for metabolic profiling.NMR Metabolomics Analysis of Parkinson's DiseaseMetabolic Signature Profiling as a Diagnostic and Prognostic Tool in Pediatric Plasmodium falciparum MalariaSterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani.Leishmania antimony resistance: what we know what we can learn from the field.Isotope labeling experiments in metabolomics and fluxomics.LC-MS metabolomics of polar compounds.Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?Determination of antiprotozoal drug mechanisms by metabolomics approaches.HILIC-MS for metabolomics: An attractive and complementary approach to RPLC-MS.Neglected diseases prioritized in Brazil under the perspective of metabolomics: A review.Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure.Evaluating drug resistance in visceral leishmaniasis: the challenges.Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage.Current knowledge of metabolomic approach in infectious fish disease studies.Murine cutaneous leishmaniasis investigated by MALDI mass spectrometry imaging.Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.Capillary electrophoresis reveals polyamine metabolism modulation in Leishmania (Leishmania) amazonensis wild type and arginase knockout mutants under arginine starvation.
P2860
Q24633552-B8A38C1A-B4C8-4699-9B57-E6B44D90EA15Q27009505-309B2307-3E42-4D4E-AC86-2D3C6F01A6B6Q27022024-2C484D2C-8E1A-4FD9-AE75-503DDCC8E004Q28073426-06B37698-0809-4B80-B1E5-915EFB5C5865Q28483977-09EF978F-4451-48CE-B097-6150596BB9B2Q28539047-933CC85F-B021-4126-AD79-10756F267DA2Q28546448-B8EB5F76-75E3-4F29-A456-83BB1F913025Q28548008-7D0C603A-3DAE-4DCC-AC66-20043DDCCEC2Q30380900-F2C91676-E1B1-4EE1-B13C-9DE0E527A4C0Q30577867-A2991DB9-D781-4D98-9D82-B73109394561Q30790484-538F86E3-BFAC-4378-AAED-93498F6331E0Q33900285-2237EE68-96D1-448D-81DB-B9A3A6AA4275Q34069469-1ED3BA6B-C030-4F18-A143-1CA302DA95A4Q34113846-166CB8E8-81B5-4E59-BC58-BA3CD3D7A411Q34277011-78EEC6DC-E91A-4DC6-B3F4-125F8CB4D6C3Q34677433-24299DCE-02B6-4BC9-833C-736F2812D158Q34693456-8AA9D579-8FE0-472A-B8B5-5093A197A398Q35077991-68D60E54-D936-4CC0-B604-66C502F9291EQ35162669-E0609AF4-6ED1-4C18-80C9-3C8413197942Q35734379-F315E37F-9FDD-42FA-A51C-372C8589C98DQ35757334-DA13FD32-6178-4C0E-88A8-D4383C5E01C6Q36407342-4B9422F0-EBD1-40EA-ACFF-96913A89D690Q36628128-FA5E0956-D8C1-455F-B3F9-719FCFB578DAQ37712969-8AB3A944-6387-4A69-AF07-77D5E759DC47Q37907925-F0CF7201-ED38-450C-BCC4-FF3D7A0A9D28Q37996964-666AB7EF-00BF-4A23-851B-4C2BC893EC6EQ38014968-C9A7DC73-E190-4BBE-85D9-D863AFDAFFE1Q38040818-B53EBF7A-B733-42BC-AC7C-C6DC228A0F86Q38111816-17EA8251-E7C0-410C-AA6E-E6954BAFEE90Q38256887-DBFFE4E0-F696-4179-A709-34840B2D36FBQ38533526-2C4B5C83-226B-4FBD-9858-65C72A486758Q38759621-D8383C00-8230-4399-BEBD-DB06F74DF14EQ38904942-4B58E56A-185F-4B6B-AA65-BA9B2B1B9DC0Q38904947-70A0A8CA-E76C-45E2-9DAF-1C4065EFB1CDQ39014583-B25DBD6F-046C-4F07-B8F1-9714B087DF92Q39101699-D0ABF1C3-A503-4BAA-99B3-593240BA0F06Q39157875-46E64BCC-5405-45E5-8830-E63FF781DA93Q39298243-BF9A0FDE-E064-476A-A6E0-E3239FC20186Q40945954-C17C029C-3A39-4E5F-BB1F-B2C5DDB58518Q41094558-AE19F453-59DE-461F-9482-8E8BF3FCEBCF
P2860
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@ast
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@en
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@nl
type
label
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@ast
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@en
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@nl
prefLabel
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@ast
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@en
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@nl
P2093
P2860
P50
P1476
Metabolomics to unveil and understand phenotypic diversity between pathogen populations
@en
P2093
David G Watson
Graham H Coombs
Jean-Claude Dujardin
Richard A Scheltema
Ruben t'Kindt
Suman Rijal
P2860
P356
10.1371/JOURNAL.PNTD.0000904
P407
P5008
P577
2010-11-30T00:00:00Z